112 related articles for article (PubMed ID: 30114)
1. The pathophysiologic basis of tardive dyskinesia.
Baldessarini RJ
Psychopharmacol Bull; 1978 Oct; 14(4):79-81. PubMed ID: 30114
[No Abstract] [Full Text] [Related]
2. Pathophysiologic basis of tardive dyskinesia.
Baldessarini RJ; Tarsy D
Adv Biochem Psychopharmacol; 1980; 24():451-5. PubMed ID: 6105793
[No Abstract] [Full Text] [Related]
3. Tardive dyskinesia: a biological appraoch.
Barbaccia ML; Trabucchi M
Prog Clin Biol Res; 1980; 39():181-93. PubMed ID: 6105670
[No Abstract] [Full Text] [Related]
4. Neuroleptic drugs and their action on different neuronal pathways.
Ungerstedt U; Herrera-Marschitz M; Forster C
J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):34-7. PubMed ID: 2858478
[TBL] [Abstract][Full Text] [Related]
5. Neuroleptic-induced tardive dyskinesia.
Jenner P; Marsden CD
Acta Psychiatr Belg; 1987; 87(5):566-98. PubMed ID: 2897761
[TBL] [Abstract][Full Text] [Related]
6. Adaptive changes in brain dopamine function as a result of neuroleptic treatment.
Jenner P; Marsden CD
Adv Neurol; 1988; 49():417-31. PubMed ID: 2894127
[No Abstract] [Full Text] [Related]
7. Use of dopamine receptor agonists to reduce dopamine receptor number as treatment for tardive dyskinesia.
Alpert M; Friedhoff AJ; Diamond F
Adv Neurol; 1983; 37():253-8. PubMed ID: 6134444
[No Abstract] [Full Text] [Related]
8. The pathophysiologic basis of tardive dyskinesia.
Tarsy D; Baldessarini RJ
Biol Psychiatry; 1977 Jun; 12(3):431-50. PubMed ID: 194633
[TBL] [Abstract][Full Text] [Related]
9. The pathophysiology of tardive dyskinesia.
Klawans HL; Carvey P; Tanner CM; Goetz CG
J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):38-41. PubMed ID: 2858479
[TBL] [Abstract][Full Text] [Related]
10. Drug therapy of tardive dyskinesia.
Kobayashi RM
N Engl J Med; 1977 Feb; 296(5):257-60. PubMed ID: 12469
[No Abstract] [Full Text] [Related]
11. Dopamine and the pathophysiology of dyskinesias induced by antipsychotic drugs.
Baldessarini RJ; Tarsy D
Annu Rev Neurosci; 1980; 3():23-41. PubMed ID: 6106450
[No Abstract] [Full Text] [Related]
12. Dogma disputed: is tardive dyskinesia due to postsynaptic dopamine receptor supersensitivity?
Jeste DV; Wyatt RJ
J Clin Psychiatry; 1981 Dec; 42(12):455-7. PubMed ID: 6118358
[TBL] [Abstract][Full Text] [Related]
13. Tardive dyskinesia presenting as gastrointestinal disorder.
Goldberg RJ; Morris PL; Lidofsky S
J Clin Psychiatry; 1990 Jun; 51(6):253-4. PubMed ID: 1971823
[TBL] [Abstract][Full Text] [Related]
14. Tardive dyskinesia: pathophysiology and animal models.
Casey DE
J Clin Psychiatry; 2000; 61 Suppl 4():5-9. PubMed ID: 10739324
[TBL] [Abstract][Full Text] [Related]
15. Association of intellectual impairment, negative symptoms, and aging with tardive dyskinesia: clinical and animal studies.
Waddington JL; Youssef HA; Molloy AG; O'Boyle KM; Pugh MT
J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):29-33. PubMed ID: 2858476
[TBL] [Abstract][Full Text] [Related]
16. Biochemical methods for predicting the occurrence of tardive dyskinesia.
Bürki HR
Commun Psychopharmacol; 1979; 3(1):7-15. PubMed ID: 38033
[No Abstract] [Full Text] [Related]
17. Animal models of tardive dyskinesia--a review.
Kulkarni SK; Naidu PS
Indian J Physiol Pharmacol; 2001 Apr; 45(2):148-60. PubMed ID: 11480221
[TBL] [Abstract][Full Text] [Related]
18. [Current status of our knowledge of the neurotropic side effects of neuroleptic drugs].
Sabbatini F; Pinessi L; Gentile S; De Mattei M; Portaleone P
Minerva Psichiatr; 1983; 24(4):145-53. PubMed ID: 6145083
[No Abstract] [Full Text] [Related]
19. Dopamine receptor function and spontaneous orofacial dyskinesia in rats during 6-month neuroleptic treatments.
Waddington JL; Cross AJ; Gamble SJ; Bourne RC
Adv Biochem Psychopharmacol; 1983; 37():299-308. PubMed ID: 6138952
[No Abstract] [Full Text] [Related]
20. Epidemiology and pathophysiology of tardive dyskinesias.
Klawans HL; Tanner CM; Goetz CG
Adv Neurol; 1988; 49():185-97. PubMed ID: 2894124
[No Abstract] [Full Text] [Related]
[Next] [New Search]
